Chimp Retirement Bill Signed

The US President has signed a bill to support the retirement of federally owned research chimpanzees over the next five years.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, IKIWANERPresident Barack Obama last week (November 27) signed a bill to support the retirement of federally owned chimpanzees once used for research by scientists at the National Institutes of Health (NIH) and elsewhere. According to The New York Times, the bill allows NIH to spend money once earmarked for research to support the move of nearly 300 federally owned chimps to a sanctuary in Keithville, Louisiana. NIH will keep 50 chimps for potential future research needs.

In a statement, NIH Director Francis Collins applauded the president’s actions, noting that that approved amendments to The Chimpanzee Health Improvement, Maintenance, and Protection (CHIMP) Act enable support for all NIH-owned and -supported chimpanzees—including retirees—for the next five years. “With the funding roadblock removed, NIH can begin to move forward with our previously stated plans to transfer all but 50 of the NIH-owned research chimpanzees, over time, into the federal sanctuary system,” Collins explained in the statement.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies